New York State Contract Reporter #PP-LA-738

SUNY Upstate Medical University Solicits Bio-Rad Quality Control Materials or Approved Equivalents

SUNY Upstate Medical University is seeking to procure quality control materials and related products, with a preference for Bio-Rad Laboratories, Inc. items or clinically equivalent alternatives. - Government Buyer: - State University of New York (SUNY), SUNY Upstate Medical University, Hospital Purchasing Department - Original Equipment Manufacturer (OEM): - Bio-Rad Laboratories, Inc. (highlighted as the preferred OEM) - Products/Services Requested: - Quality control materials and related products - No specific part numbers or quantities provided - Vendor Requirements: - Vendors may offer Bio-Rad products or clinically equivalent alternatives - Equivalency must be demonstrated with supporting clinical documentation - Vendors must provide equipment for examination, demonstration, and trial at no cost - Vendors must be authorized to sell Bio-Rad products under the Premier contract or be approved as an equivalent - Notable Requirements: - Procurement is through Premier contract PP-LA-738 - Subject to New York State Finance Law §139 j&k (Lobbying Law), restricting communications to the designated contact - No prior similar contracts awarded in the past five years - Place of Performance/Delivery: - SUNY Upstate Medical University Hospital Purchasing Department, 750 East Adams Street, Suite 2050 Sarah Loguen Center, Syracuse, NY 13210

Description

SUNY Upstate Medical University intends to purchase Bio-Rad Laboratories, Inc. Quality Control Materials and Related Products through a contract awarded by Premier. The procurement is authorized under section 163 (3) (vi) allowing purchases from a consortium without a formal competitive process when justified by price. Vendors offering equivalent products may contact the university to discuss the procurement, provided they demonstrate clinical equivalency and provide supporting documentation and equipment for trial. The procurement is subject to New York State Finance Law §139 j&k (Lobbying Law), restricting contact to the designated individual.

View original listing